Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

NCT01505114 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

594

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Maraviroc
DRUG: Emtricitabine
DRUG: Tenofovir disoproxil fumarate
OTHER: Maraviroc placebo
OTHER: Emtricitabine placebo
OTHER: Tenofovir disoproxil fumarate placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]